Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2.18B
-
Number of holders
-
1296
-
Total 13F shares, excl. options
-
138M
-
Shares change
-
-1.44M
-
Total reported value, excl. options
-
$14.7B
-
Value change
-
-$144M
-
Put/Call ratio
-
1.04
-
Number of buys
-
534
-
Number of sells
-
-534
-
Price
-
$106.46
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q2 2024
1,389 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q2 2024.
NOVARTIS AG - Ordinary Shares (NVS) has 1,296 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 138M shares
of 2.18B outstanding shares and own 6.31% of the company stock.
Largest 10 shareholders include Dodge & Cox (12.2M shares), PRIMECAP MANAGEMENT CO/CA/ (12.2M shares), MORGAN STANLEY (7.42M shares), DIMENSIONAL FUND ADVISORS LP (7.41M shares), LOOMIS SAYLES & CO L P (5.95M shares), FRANKLIN RESOURCES INC (5.34M shares), BANK OF AMERICA CORP /DE/ (4.85M shares), WELLINGTON MANAGEMENT GROUP LLP (4.38M shares), GOLDMAN SACHS GROUP INC (3.08M shares), and Cullen Capital Management, LLC (2.87M shares).
This table shows the top 1296 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.